Skip to content
The Colorado Natural Medicine Health Act Tracker and Bulletin are now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Colorado Natural Medicine Advisory Bulletin

      Everything you need to know about implementing the NMHA in Colorado.

      Read the Latest

      News & Press Releases

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Ibogaine Patents
      Ibogaine Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Law Trackers

      Mapping psychedelic drug policy reform across the United States and worldwide.

      Worldwide Tracker
      U.S. Tracker
      Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

  • Post published:July 5, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Voting Results of AGSM

Wesana Health Announces Voting Results of AGSM

  • Post published:June 9, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

  • Post published:March 21, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Receipt of Short-Term Loan

Wesana Health Announces Receipt of Short-Term Loan

  • Post published:December 21, 2022
  • Post category:Press Release
Read more about the article Wesana Announces Sale of Clinic Management Services Organization

Wesana Announces Sale of Clinic Management Services Organization

  • Post published:September 3, 2022
  • Post category:Press Release
Read more about the article Wesana Announces Second Quarter 2022 Financial Results

Wesana Announces Second Quarter 2022 Financial Results

  • Post published:August 30, 2022
  • Post category:Press Release
Read more about the article Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

  • Post published:June 8, 2022
  • Post category:Press Release
Read more about the article Wesana Health Provides Strategic and Operational Updates

Wesana Health Provides Strategic and Operational Updates

  • Post published:January 12, 2022
  • Post category:Press Release
Read more about the article Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

  • Post published:January 11, 2022
  • Post category:Press Release
Read more about the article MAPS and Wesana Health Resume Negotiations

MAPS and Wesana Health Resume Negotiations

  • Post published:December 14, 2021
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.